The effectiveness of cross-tapering switching to ziprasidone in patients with schizophrenia or schizoaffective disorder.

CONCLUSION: Cross-tapering switching to ziprasidone is effective for patients with schizophrenia spectrum disorders. Beyond the efficacy of the procedure, favorable metabolic profiles show that switching to ziprasidone may be helpful for maintenance therapy over an extended period. PMID: 25395978 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/25395978?dopt=Abstract

Source: Psychiatry Investigation - December 2, 2014 Category: Psychiatry Tags: Psychiatry Investig Source Type: research